Cantor Fitzgerald upgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Hold to Buy with a price target of $157.00 (from $121.00).Analyst Irina ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE